What the evolving science of skin lipid architecture teaches us about a new approach to well-ageing.

For decades, skincare innovation has often been organised around individual concerns. Dryness requires hydration. Visible redness requires soothing. Wrinkles require an anti-ageing active. Each concern generates its own claims, ingredient strategies and formulation solutions. But skin biology doesn’t work in isolation.

Barrier function, hydration, environmental response and visible skin quality are closely interconnected. As our understanding of ageing skin develops, this raises an interesting question for formulators and ingredient innovators: could some of the changes we have traditionally targeted independently share a more fundamental starting point?

The Hidden Architecture of Ageing

The barrier properties of the stratum corneum depend on corneocytes embedded within a highly organised extracellular lipid matrix. Ceramides, cholesterol and free fatty acids are arranged into lamellar structures that play a critical role in maintaining barrier integrity and regulating transepidermal water loss.

With age, this architecture changes:

  • Lipid depletion: Levels of vital barrier lipids—particularly ceramides—decline significantly.
  • Structural disruption: Alterations in lipid composition lead to an increasingly compromised barrier.
  • External stress: Environmental aggressors exert further pressure on an already vulnerable system.

The physical consequences are familiar: dryness, roughness, reduced resilience and greater susceptibility to visible environmental stress — all contributing to changes in skin quality associated with ageing.

Instead of beginning with the visible sign and asking how to correct it, what happens if we begin with what ageing skin has lost? Biomimetic lipid science provides the answer.

A Biomimetic Perspective on AvenaPLex

At its simplest, biomimicry is about understanding the components and structures skin naturally uses and finding ways to work with that biology. For the skin barrier, lipids are central to that approach.

It was through this biological lens that we began to look at AvenaPLex differently. AvenaPLex is an oat-derived active lipid complex containing naturally occurring oat lipids including phytoceramides, phospholipids, sterols and free fatty acids, alongside oat-derived bioactives including avenanthramides. Its patented extraction and concentration process preserves and concentrates valuable polar lipid fractions.

For formulators, the significance lies not simply in any one component, but in the multi-lipid profile itself. It presents a compelling biomimetic proposition: replenish ageing skin with lipid components it already knows.

Viewed this way, the existing efficacy data starts to tell a more connected story.

Replenishment and Organisation

In a human skin explant model, 1% AvenaPLex produced a statistically significant 29% increase in neutral lipid content after five days compared with untreated control. Replenishment, however, is only part of effective barrier support. AvenaPLex has also been shown to improve the organisation of intercellular lipid lamellae, indicating a more abundant and better organised epidermal lipid structure.

Functional Barrier Performance

Importantly, there is evidence that this structure translates into function. In vivo testing with 1% AvenaPLex demonstrated a statistically significant 9% reduction in transepidermal water loss within one hour compared with placebo.

Replenishment supports organisation; organisation supports function. And from there, the lipid story begins to broaden.

The Cascade Effect: From Barrier to Well-Ageing

Barrier function and hydration may appear as separate lines on a formulation brief, but biologically they are closely connected.

A more effective lipid barrier helps limit water loss, while AvenaPLex has also demonstrated support for hyaluronic acid and improvements in skin hydration over time.

Beyond its lipid profile, AvenaPLex contains naturally occurring oat bioactives, including avenanthramides with antioxidant activity. Studies have also demonstrated reductions in UV-induced erythema when AvenaPLex was applied both before and after UV exposure.

Then we arrive at an endpoint more traditionally associated with anti-ageing efficacy. After 84 days, AvenaPLex demonstrated a statistically significant 59% reduction in the appearance of wrinkles versus placebo, alongside improvements in skin roughness.

Individually, these are compelling efficacy endpoints. Together, they reveal a broader pattern:

Lipid replenishment → lipid organisation → barrier support → hydration & environmental stress support → visible well-ageing.

The wrinkle hasn’t disappeared from the well-ageing conversation. We have simply changed where the conversation begins. AvenaPLex can therefore be viewed not as a series of disconnected claims, but as a biomimetic oat lipid system for barrier-first, well-ageing formulation — one in which its multi-component lipid profile and efficacy data connect across multiple aspects of ageing skin.

Conscious Innovation From Crop to Formulation

The story of AvenaPLex starts with the oat itself. Sourced from a renewable oat feedstock, it is produced from the oat extract stream of a wider oat processing operation. This creates an upcycled oat lipid story, transforming a valuable lipid-rich fraction into a premium cosmetic active.

Its manufacturing process uses plant-derived ethanol extraction, while by-products across the wider operation are directed into food, feed and biogas streams wherever possible, helping maximise the value derived from the crop and supporting more circular resource use.

There is a fitting parallel here. Within skin, the technology is about making intelligent use of lipid components familiar to its natural architecture. Within production, it is about making intelligent use of the valuable components already present within the oat.

Rethinking The Future of Well-Ageing

Innovation begins with understanding what nature already provides — and using it more intelligently.

The future of well-ageing isn’t about treating isolated consequences at the surface. It begins by understanding what has changed beneath them and rebuilding skin with what it already knows.

And perhaps that is where the future of well-ageing formulation becomes most interesting. Instead of simply asking, “how do we correct a sign of ageing?”, we can ask: “what changes within ageing skin — and how can formulation help support what is being lost?” For AvenaPLex, the answer was already present within the science. The efficacy hasn’t changed and the studies haven’t changed. What has changed is the connection between them.

Once that connection becomes clear, the proposition is surprisingly simple: replenish what is lost, support the architecture skin relies upon and help create the conditions for healthier, more resilient well-ageing skin.

Perhaps the next generation of well-ageing won’t begin by correcting the consequences of ageing in isolation. It will begin by understanding what has changed beneath them — and rebuilding skin with what it knows.

Explore the full AvenaPLex® data pack for supporting efficacy data and technical information.